Prostate Intelligence™
Lucida Medical
Product specifications |
Information source:
Vendor
Last updated: Oct. 26, 2023 |
General | |
---|---|
Product name | Prostate Intelligence™ |
Company | Lucida Medical |
Subspeciality | Abdomen |
Modality | MR |
Disease targeted | Prostate cancer |
Key-features | AI- supported prostate segmentation and volume, lesion segmentation, volumes and risk scores, PI-RADS v2.1 scoring support, structured report |
Suggested use | During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion, |
Data characteristics | |
Population | Prostate MRI scans with suspicion of prostate cancer, males >21 years |
Input | MRI, T2, DWI, DCE (optional) |
Input format | DICOM |
Output | Segmentation overlay, RTSTRUCT export for biopsy and 3D vizualization, structured report with key images, volumes and risk score |
Output format | DICOM |
Technology | |
Integration | Integration in standard reading environment (PACS) |
Deployment | Locally on dedicated hardware, Cloud-based |
Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | 1 - 10 minutes |
Certification | |
CE
|
Certified,
Class IIb
, MDR
|
FDA
|
No or not yet |
Market presence | |
On market since | 05-2021 |
Distribution channels | Eureka Clinical AI |
Countries present (clinical, non-research use) | |
Paying clinical customers (institutes) | |
Research/test users (institutes) | |
Pricing | |
Pricing model | Pay-per-use, Subscription |
Based on | Number of analyses, Number of installations |
Evidence | |
Peer reviewed papers on performance | |
Non-peer reviewed papers on performance | |
Other relevant papers |
|